Literature DB >> 10779592

Characterization of domains of the phosphoriboprotein P0 of Plasmodium falciparum.

S Chatterjee1, S Singh, R Sohoni, V Kattige, C Deshpande, S Chiplunkar, N Kumar, S Sharma.   

Abstract

Antibodies against the amino-terminal domain of the Plasmodium falciparum P0 phosphoriboprotein were detected extensively in immune people living in malaria endemic areas of India. It has been shown earlier that specific antibodies raised against the PfP0N domain (17-61 amino acid) of the PfP0 protein inhibit P. falciparum growth in vitro. To study the properties of the rest of the protein, the remaining 61-316 amino acids on the carboxy-side of the PfP0 protein were expressed as a glutathione-S-transferase fusion protein (PfP0C). Antibodies raised against PfP0C identified the 38 kDa P0 protein on a parasite Western blot analysis. An ELISA assay using both the PfP0N and PfP0C fusion proteins showed no reactivity with malaria patient sera samples, but showed extensive reactions with the immune sera. Antibodies against both the PfP0C and PfP0N domains were raised in rabbits and different inbred strains of mice. T-cells from immunized mice showed lymphoproliferation when presented with PfP0 protein domains. IgG from both anti-PfP0N and anti-PfP0C sera inhibited the growth of P. falciparum in vitro in a concentration dependent manner. The IgG did not show any significant effect on the growth of intraerythrocytic stages, but specifically inhibited re-invasion of red cells. Merozoites and sexual stages showed surface reactivity to both anti-PfP0N and anti-PfP0C antibodies in immunofluorescence assays. These properties strongly indicate PfP0 as a possible target for invasion-blocking antibodies.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10779592     DOI: 10.1016/s0166-6851(99)00226-1

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  17 in total

1.  Distinct Th1- and Th2-Type prenatal cytokine responses to Plasmodium falciparum erythrocyte invasion ligands.

Authors:  Indu Malhotra; Peter Mungai; Eric Muchiri; John Ouma; Shobhona Sharma; James W Kazura; Christopher L King
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

2.  Antibodies against ribosomal phosphoprotein P0 of Plasmodium falciparum protect mice against challenge with Plasmodium yoelii.

Authors:  S Chatterjee; S Singh; R Sohoni; N J Singh; A Vaidya; C Long; S Sharma
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

3.  The P domain of the P0 protein of Plasmodium falciparum protects against challenge with malaria parasites.

Authors:  K Rajeshwari; Kalpesh Patel; Savithri Nambeesan; Monika Mehta; Alfica Sehgal; Tirtha Chakraborty; Shobhona Sharma
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

4.  A shared antigen among Babesia species: ribosomal phosphoprotein P0 as a universal babesial vaccine candidate.

Authors:  M Alaa Terkawi; Honglin Jia; Aboge Gabriel; Youn-Kyoung Goo; Yoshifumi Nishikawa; Naoaki Yokoyama; Ikuo Igarashi; Kozo Fujisaki; Xuenan Xuan
Journal:  Parasitol Res       Date:  2007-09-06       Impact factor: 2.289

5.  Erythrocytic stage-dependent regulation of oligomerization of Plasmodium ribosomal protein P2.

Authors:  Sudipta Das; Rajagopal Sudarsan; Subramanian Sivakami; Shobhona Sharma
Journal:  J Biol Chem       Date:  2012-10-11       Impact factor: 5.157

6.  Fine mapping of Plasmodium falciparum ribosomal phosphoprotein PfP0 revealed sequences with highly specific binding activity to human red blood cells.

Authors:  Gabriela Arevalo-Pinzon; Hernando Curtidor; Claudia Reyes; Martha Pinto; Carolina Vizcaíno; Manuel A Patarroyo; Manuel E Patarroyo
Journal:  J Mol Med (Berl)       Date:  2009-09-21       Impact factor: 4.599

7.  The Leishmania infantum acidic ribosomal protein P0 administered as a DNA vaccine confers protective immunity to Leishmania major infection in BALB/c mice.

Authors:  Salvador Iborra; Manuel Soto; Javier Carrión; Ana Nieto; Edgar Fernández; Carlos Alonso; Jose M Requena
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

8.  Identification of a hypothetical membrane protein interactor of ribosomal phosphoprotein P0.

Authors:  K Aruna; Tirtha Chakraborty; Savithri Nambeesan; Abdul Baru Mannan; Alfica Sehgal; Seema R Bhalchandara; Shobhona Sharma
Journal:  J Biosci       Date:  2004-03       Impact factor: 1.826

9.  Protective properties and surface localization of Plasmodium falciparum enolase.

Authors:  Ipsita Pal-Bhowmick; Monika Mehta; Isabelle Coppens; Shobhona Sharma; Gotam K Jarori
Journal:  Infect Immun       Date:  2007-09-04       Impact factor: 3.441

10.  Can prenatal malaria exposure produce an immune tolerant phenotype? A prospective birth cohort study in Kenya.

Authors:  Indu Malhotra; Arlene Dent; Peter Mungai; Alex Wamachi; John H Ouma; David L Narum; Eric Muchiri; Daniel J Tisch; Christopher L King
Journal:  PLoS Med       Date:  2009-07-28       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.